The findings suggest that the activation of the VEGF/VEGFR-1 pathway may play an essential role in the angiogenic process in COVID-19 patients, contributing to the development of new vessels in the areas of hypoxia, inflammation and viral replication, which in turn contributes to the increase in vascular hypertrophy observed in this study. This evidence concerns the gene VEGFA and COVID-19.